Bladder Cancer

1. Front Matter

   Pages i-xv

   PDF

2. Improving Bladder Cancer Staging

   1. Front Matter

      Pages 1-1

      PDF

   2. Approaches to Carcinoma In Situ (CIS)

      • J. Stephen Jones

      Pages 5-18

   3. Fluorescence Cytoscopy

      • Philippe E. Spiess, H. Barton Grossman

      Pages 19-24

   4. Restaging TURBT

      • David Berger, Jeffrey M. Holzbeierlein

      Pages 26-33

   5. Understaging T2: Limitations of Pelvic Imaging

      • Jon M. Willatt, Richard H. Cohan

      Pages 35-39

   6. MRI Endorectal Coil

      • Saroja Adusumilli, Hero Hussain

      Pages 41-47

   7. PET Imaging: Advances in the Detection of Locally Advanced and Nodal Disease

      • Morand Piert

      Pages 49-53

   8. Detection of Extravesical Disease: A Lack of Bladder Cancer Markers

      • Andrew A. Stec, Michael S. Cookson, Sam S. Chang

      Pages 55-65

   9. Identification of Nodal Metastases: The role of Iron Oxide Enhanced MRI

      • Bernard H. Bochner

      Pages 67-77

   10. Presence and Significance of Micrometastases

       • Stephen Boorjian, Douglas S. Scherr

       Pages 79-88

3. Optimizing Treatment of Localized Disease

   1. Front Matter

      Pages 91-91

      PDF

   2. Perioperative Intravesical Therapy

      • Ralph Madeb, Edward Messing

      Pages 93-103

   3. BCG Refractory Disease

      • Tara Allen, Graham F. Greene

      Pages 105-113

   4. Beyond BCG: Gemcitabine

      • Ganesh V. Raj, Guido Dalbagni

      Pages 115-125

   5. Beyond BCG: Taxanes

      • James M. McKiernan, Phillip M. Pierorazio

      Pages 127-131

   6. Extended Lymph Node Dissection

      • Michael E. Woods, Marcus L. Quek

      Pages 134-145

   7. Prostate Capsule Sparing Cystectomy

      • Alon Z. Weizer, Timothy Schuster

      Pages 147-158

   8. Preservation of Reproductive Organs in Women

      • Lambda Msezane and, Gary D. Steinberg, Gary D. Steinberg

      Pages 159-168

   9. Nerve Sparing Radical Cystectomy

      • Edward M. Schaeffer, Matthew E. Nielsen, Mark L. Gonzalgo, Mark P. Schoenberg

      Pages 169-175

In Bladder Cancer: Moving the Field Forward, Cheryl Lee, David Wood, and a panel of leading authorities and researchers provide a comprehensive review of the related literature, while providing insights into the obstacles of improved survival and discuss methods to advance the field of Bladder Cancer care. Their work aims to spur innovative thoughts and approaches to common problems in the management of early stage and advanced disease. The book discusses at length the state of bladder cancer staging and the optimal treatment for localized disease. Additional sections review the applications of existing systemic therapies and look at the infrastructure needed to support translational research efforts. Groundbreaking and authoritative, Bladder Cancer: Moving the Field Forward, is the definitive text on the current state of bladder cancer care and a must have for all urologists and medical oncologists who wish to provide their patients with the most comprehensive care.

• BCG Refractory Disease
• Bladder Cancer
• Bladder Cancer Staging
• Carcinom
• Cystectomy
• Nerve Sparing Cystectomy
• PET Imaging
• Staging
• TURBT

From the reviews: “This is a summation of the active issues involved in the diagnosis and treatment of bladder urothelial carcinoma (UC). … comprehensive guide to current standards of care and emerging technologies … . medical oncologists should also strongly consider adding this to their libraries. Residents would benefit from this book … . valuable addition to the library of any practicing urologist. The authors strive, successfully, to provide the latest data based on high levels of evidence … in the diagnosis, management, and eradication of bladder cancer.” (Deborah Tova Glassman, Doody’s Review Service, March, 2010)

• Dept. Urology, University of Michigan Health System, Ann Arbor, U.S.A.

  Cheryl T. Lee, David P. Wood

Policies and ethics